180 related articles for article (PubMed ID: 36564445)
41. The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease.
Dogra N; Mani RJ; Katare DP
Cell Mol Neurobiol; 2022 Mar; 42(2):315-332. PubMed ID: 33649989
[TBL] [Abstract][Full Text] [Related]
42. LRRK2 modifies α-syn pathology and spread in mouse models and human neurons.
Bieri G; Brahic M; Bousset L; Couthouis J; Kramer NJ; Ma R; Nakayama L; Monbureau M; Defensor E; Schüle B; Shamloo M; Melki R; Gitler AD
Acta Neuropathol; 2019 Jun; 137(6):961-980. PubMed ID: 30927072
[TBL] [Abstract][Full Text] [Related]
43. Association of SNCA variants with α-synuclein of gastric and colonic mucosa in Parkinson's disease.
Chung SJ; König IR; Lohmann K; Hinrichs F; Kim J; Ryu HS; Lee HJ; Kim K; Lee JH; Jung KW; Kim MJ; Kim MJ; Kim YJ; Yun SC; Hong SM; Myung SJ; Klein C
Parkinsonism Relat Disord; 2019 Apr; 61():151-155. PubMed ID: 30424941
[TBL] [Abstract][Full Text] [Related]
44. Reelin protects against pathological α-synuclein accumulation and dopaminergic neurodegeneration after environmental enrichment in Parkinson's disease.
Cho E; Kim K; Kim H; Cho SR
Neurobiol Dis; 2022 Dec; 175():105898. PubMed ID: 36270619
[TBL] [Abstract][Full Text] [Related]
45. Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice.
Pan-Montojo F; Schwarz M; Winkler C; Arnhold M; O'Sullivan GA; Pal A; Said J; Marsico G; Verbavatz JM; Rodrigo-Angulo M; Gille G; Funk RH; Reichmann H
Sci Rep; 2012; 2():898. PubMed ID: 23205266
[TBL] [Abstract][Full Text] [Related]
46. Heparan sulfate proteoglycans mediate prion-like α-synuclein toxicity in Parkinson's in vivo models.
Chen M; Vincent J; Ezeanii A; Wakade S; Yerigenahally S; Mor DE
Life Sci Alliance; 2022 Nov; 5(11):. PubMed ID: 35790300
[TBL] [Abstract][Full Text] [Related]
47. Α-synuclein immunotherapy blocks uptake and templated propagation of misfolded α-synuclein and neurodegeneration.
Tran HT; Chung CH; Iba M; Zhang B; Trojanowski JQ; Luk KC; Lee VM
Cell Rep; 2014 Jun; 7(6):2054-65. PubMed ID: 24931606
[TBL] [Abstract][Full Text] [Related]
48. The antioxidant Rutin counteracts the pathological impact of
Christmann A; Gries M; Scholz P; Stahr PL; Law JKY; Schulte S; Martin M; Lilischkis R; Ingebrandt S; Keck CM; Schäfer KH
Biol Chem; 2022 Jan; 403(1):103-122. PubMed ID: 34582634
[TBL] [Abstract][Full Text] [Related]
49. A β-Wrapin Targeting the N-Terminus of α-Synuclein Monomers Reduces Fibril-Induced Aggregation in Neurons.
Szegő ÉM; Boß F; Komnig D; Gärtner C; Höfs L; Shaykhalishahi H; Wördehoff MM; Saridaki T; Schulz JB; Hoyer W; Falkenburger BH
Front Neurosci; 2021; 15():696440. PubMed ID: 34326719
[TBL] [Abstract][Full Text] [Related]
50. Short communication: Tryptic β-casein hydrolysate modulates enteric nervous system development in primary culture.
Cossais F; Clawin-Rädecker I; Lorenzen PC; Klempt M
J Dairy Sci; 2017 May; 100(5):3396-3403. PubMed ID: 28259395
[TBL] [Abstract][Full Text] [Related]
51. The enteric nervous system in PD: gateway, bystander victim, or source of solutions.
Shannon K; Vanden Berghe P
Cell Tissue Res; 2018 Jul; 373(1):313-326. PubMed ID: 29936550
[TBL] [Abstract][Full Text] [Related]
52. Intestinal microbiota shapes gut physiology and regulates enteric neurons and glia.
Vicentini FA; Keenan CM; Wallace LE; Woods C; Cavin JB; Flockton AR; Macklin WB; Belkind-Gerson J; Hirota SA; Sharkey KA
Microbiome; 2021 Oct; 9(1):210. PubMed ID: 34702353
[TBL] [Abstract][Full Text] [Related]
53. Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease.
Kelly LP; Carvey PM; Keshavarzian A; Shannon KM; Shaikh M; Bakay RA; Kordower JH
Mov Disord; 2014 Jul; 29(8):999-1009. PubMed ID: 24898698
[TBL] [Abstract][Full Text] [Related]
54. Intrastriatal injection of preformed alpha-synuclein fibrils alters central and peripheral immune cell profiles in non-transgenic mice.
Earls RH; Menees KB; Chung J; Barber J; Gutekunst CA; Hazim MG; Lee JK
J Neuroinflammation; 2019 Dec; 16(1):250. PubMed ID: 31796095
[TBL] [Abstract][Full Text] [Related]
55. Modeling α-Synucleinopathy in Organotypic Brain Slice Culture with Preformed α-Synuclein Amyloid Fibrils.
Roux A; Wang X; Becker K; Ma J
J Parkinsons Dis; 2020; 10(4):1397-1410. PubMed ID: 32716318
[TBL] [Abstract][Full Text] [Related]
56. Neuroprotective Effects of Trehalose and Sodium Butyrate on Preformed Fibrillar Form of α-Synuclein-Induced Rat Model of Parkinson's Disease.
Kakoty V; K C S; Dubey SK; Yang CH; Taliyan R
ACS Chem Neurosci; 2021 Jul; 12(14):2643-2660. PubMed ID: 34197084
[TBL] [Abstract][Full Text] [Related]
57. Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons.
Er S; Hlushchuk I; Airavaara M; Chmielarz P; Domanskyi A
J Vis Exp; 2020 Aug; (162):. PubMed ID: 32865527
[TBL] [Abstract][Full Text] [Related]
58. Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes.
Kuo YM; Li Z; Jiao Y; Gaborit N; Pani AK; Orrison BM; Bruneau BG; Giasson BI; Smeyne RJ; Gershon MD; Nussbaum RL
Hum Mol Genet; 2010 May; 19(9):1633-50. PubMed ID: 20106867
[TBL] [Abstract][Full Text] [Related]
59. Expression pattern and localization of alpha-synuclein in the human enteric nervous system.
Böttner M; Zorenkov D; Hellwig I; Barrenschee M; Harde J; Fricke T; Deuschl G; Egberts JH; Becker T; Fritscher-Ravens A; Arlt A; Wedel T
Neurobiol Dis; 2012 Dec; 48(3):474-80. PubMed ID: 22850485
[TBL] [Abstract][Full Text] [Related]
60. Prion-like propagation of α-synuclein in the gut-brain axis.
Chen Y; Shao Q; Yuan YH; Chen NH
Brain Res Bull; 2018 Jun; 140():341-346. PubMed ID: 29894766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
